Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries.
about
The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countriesUsing Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies.Collection of real-world data on nivolumab's effectiveness in renal cell carcinoma: rationale for an observational study.Use of Social Media in the Assessment of Relative Effectiveness: Explorative Review With Examples From Oncology.
P2860
Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countries.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Relative effectiveness assessm ...... cisions in European countries.
@en
Relative effectiveness assessm ...... cisions in European countries.
@nl
type
label
Relative effectiveness assessm ...... cisions in European countries.
@en
Relative effectiveness assessm ...... cisions in European countries.
@nl
prefLabel
Relative effectiveness assessm ...... cisions in European countries.
@en
Relative effectiveness assessm ...... cisions in European countries.
@nl
P2093
P2860
P356
P1433
P1476
Relative effectiveness assessm ...... cisions in European countries.
@en
P2093
H G Leufkens
K Meijboom
S Kleijnen
T Leonardo Alves
V Vervölgyi
P2860
P304
P356
10.1093/ANNONC/MDW233
P577
2016-06-20T00:00:00Z